Unsolicited applications
Klosterneuburg · permanent
Seed · $5M · 153d ago Posted 1y ago
Have your AI draft the answers and brief you on Graph Therapeutics→Why join Graph Therapeutics?
Picture immune diseases treated by matching each patient to the therapy their immune system actually needs, and Graph Therapeutics, a Vienna precision-immunology company, is aiming at that. If its data layer works, drug developers and clinicians across immune disease could come to rely on it. A $5M seed round from Daphni, Merantix Capital and SquareOne Venture Capital brings its total to $9M across four rounds, with one open operations role.
JustBacked's take, based on Graph Therapeutics's own site and its funding and hiring data.
The full description is on the company's site.